Maintenance Dose of Propranolol When Heart Rate is Below 90 bpm
If the heart rate is currently less than 90 bpm and already controlled, maintain the current propranolol dose that achieved this target without further titration.
Context-Specific Dosing Guidance
The appropriate maintenance dose depends entirely on the indication for propranolol therapy:
For Infantile Hemangiomas
The maintenance dose should be 2-3 mg/kg/day divided into doses, as this range has demonstrated superior efficacy 1. The FDA-approved formulation specifically recommends a maintenance dose of 1.7 mg/kg twice daily (3.4 mg/kg/day total) 1. This dosing achieves complete or nearly complete resolution in 60% of patients compared to only 4% with placebo 1.
- Key consideration: Lower doses (1 mg/kg/day) may be necessary if comorbidities exist (such as PHACE syndrome) or if adverse effects like sleep disturbances occur 1
- Administer with or after feeding and hold doses during diminished oral intake or vomiting to prevent hypoglycemia 1
For Hypertension
The usual maintenance dose is 120-160 mg once daily using extended-release formulations 2. Since your patient's heart rate is already below 90 bpm, this suggests adequate beta-blockade has been achieved.
- Initial dosing typically starts at 80 mg daily
- Some patients may require up to 640 mg daily for blood pressure control 2
- Research shows that 80-160 mg daily produces most of the antihypertensive effect 3
For Angina Pectoris
The average optimal maintenance dose is 160 mg once daily 2, with a range of 80-320 mg depending on response.
For Migraine Prophylaxis
The effective maintenance dose range is 160-240 mg once daily 2.
Clinical Pitfalls to Avoid
Do not use heart rate as the sole endpoint for all indications: While a heart rate of 55-60 bpm is traditionally targeted for variceal hemorrhage prophylaxis, recent evidence shows that achieving ≥25% heart rate reduction from baseline does not correlate with improved outcomes 4
Avoid abrupt discontinuation: Always taper gradually over several weeks to prevent rebound effects 2
Extended-release vs immediate-release formulations are not interchangeable: Extended-release produces lower blood levels and requires retitration 2
Monitoring Parameters
Once heart rate is controlled below 90 bpm:
- Continue current dose without further titration
- Monitor for hypotension, bradycardia (especially if heart rate drops below 55 bpm)
- Assess for sleep disturbances or other CNS effects
- For pediatric patients with hemangiomas, monitor for hypoglycemia and temperature instability 5
The fundamental principle: if the therapeutic goal (heart rate <90 bpm) is achieved without adverse effects, maintain that dose as the maintenance regimen.